Brilliance is a high-performance medical device to treat newborns with severe jaundice. Jaundice is a serious health risk for babies if left untreated. Because of the high price of standard phototherapy devices, most hospitals in the developing world either do not have phototherapy or have substandard devices that provide ineffective treatment.
Brilliance has been optimized for these settings with the following features:
Whereas the standard compact fluorescent light phototherapy devices only treat 42 babies before bulb replacement is required to maintain its effectiveness, a Brilliance device is estimated to treat approximately 1,042 babies.
In late 2010, D-Rev licensed Brilliance to Chennai-based Phoenix Medical Systems. Phoenix is the largest manufacturer and seller of quality neonatal care equipment in India with 70% of the market share of compact florescent bulb phototherapy devices in the country. Phoenix will manufacture, distribute, and sell Brilliance throughout India and much of the rest of the world. Over the next five years, D-Rev and Phoenix aim to treat two million newborns in India alone.
Publicly available: yes
Countries where available: Worldwide
Price range (USD): over 200 USD
Dimensions: 159.5 cm x 71 cm x 71 cm
Weight: 20 kg
If you are aware of any updates to the Brilliance: Neonatal Jaundice Treatment project please complete the form or send an email to [email protected]